Literature DB >> 8730324

Inhalers and nebulizers: which to choose and why.

S Pedersen1.   

Abstract

It is obvious that many factors should be considered when an inhaler is prescribed. Based upon the information discussed above, a rational inhaler strategy could be as follows: (1) Children < or = 5 years and elderly patients are prescribed a spacer with a valve system (and a face mask for the children) for the delivery of all drugs. When they are severely obstructed, some may need a nebulizer. If the patient cannot be taught the correct use of a spacer, a nebulizer should be prescribed. (2) Children > or = 5 years and adults are prescribed a spacer or a Turbuhaler for the administration of inhaled corticosteroids and a dry powder inhaler (preferably multiple dose) or a breath-actuated MDI for other drugs. If these alternatives are not available or the patient prefers, a conventional MDI can be used (preferably not for other corticosteroids than fluticasone propionate) provided that careful tuition is given. Fluticasone dipropionate may be given by DPI, Spacer or MDI. (3) Nebulizers are mainly reserved for severe acute attacks of bronchoconstriction. With this approach, most patients can be taught effective inhaler use with a minimum of instructional time. Finally, it must always be remembered to consider the patient's wish, since prescription of an inhaler which the physician likes but the patient does not is likely to reduce compliance.

Entities:  

Mesh:

Year:  1996        PMID: 8730324     DOI: 10.1016/s0954-6111(96)90201-2

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

Review 1.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 2.  Treatment of childhood asthma. Options and rationale for inhaled therapy.

Authors:  C V Powell; M L Everard
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of inhaled antimicrobials.

Authors:  Chris Stockmann; Jessica K Roberts; Venkata K Yellepeddi; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

4.  A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital.

Authors:  A L Dewar; A Stewart; J J Cogswell; G J Connett
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

Review 5.  Once-daily inhaled corticosteroids in children with asthma: nebulisation.

Authors:  G Shapiro
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Randomised placebo controlled trial of beta agonist dose reduction in asthma.

Authors:  T W Harrison; J Oborne; P J Wilding; A E Tattersfield
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 7.  Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

Authors:  K M Hvizdos; B Jarvis
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

Review 8.  Use of inhaler devices in pediatric asthma.

Authors:  Fernando Maria De Benedictis; David Selvaggio
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 9.  Optimal management of asthma in elderly patients: strategies to improve adherence to recommended interventions.

Authors:  Dianne P Goeman; Jo A Douglass
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

10.  E-cigarette aerosol collection using converging and straight tubing Sections: Physical mechanisms.

Authors:  Markus Hilpert; Vesna Ilievski; Shao-Yiu Hsu; Ana M Rule; Pablo Olmedo; German Drazer
Journal:  J Colloid Interface Sci       Date:  2020-10-12       Impact factor: 8.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.